Dong Qu - Chinese Academy of Medical Sciences, Peking Union Medical College

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 13 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Cell Carcinoma: a Phase 2 Clinical Trial

Wen Zhang,Xiaowei Chen,Liyan Xue,Zhichao Jiang,Dong Qu, Zhaoyang Yang,Jianjun Qin,Zhen Wang, Miaomiao Zhang,Yong Li,Aiping Zhou,Shugeng Gao

International journal of surgery (London, England)no. 6 (2025): 3831-3837

引用0浏览0WOS引用

Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Phase II Trial

Wen Zhang,Yong Li,Liyan Xue,Dong Qu, Zhichao Jiang,Shugeng Gao,Aiping Zhou

Journal of Clinical Oncology（2024）

引用0浏览0引用

Table S1 from Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma

Jing Huang,Binghe Xu,Hongnan Mo, Weilong Zhang, Xuelian Chen, Dawei Wu,Dong Qu, Xingyuan Wang,Bo Lan, Beibei Yang, Pei Wang,Hongtu Zhang, Qing Yang,Yuchen Jiao

openalex（2023）

引用0浏览0引用

Figure S1-S4 from Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma

Jing Huang,Binghe Xu,Hongnan Mo,Weilong Zhang,Xuelian Chen,Dawei Wu,Dong Qu,Xingyuan Wang,Bo Lan, Beibei Yang,Pei Wang,Hongtu Zhang,Qing Yang,Yuchen Jiao

openalex（2023）

引用0浏览0引用

Camrelizumab in Combination with Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm, Open-Label, Phase II Study

Zhen Wang,Xiankai Chen,Yong Li, Jianjun Qin, Yuan Fang, Zhaoyang Yang,Yan Fang,Dong Qu, Ruixiang Zhang,Qingfeng Zheng, Xiaozheng Kang,Liyan Xue, Jing Huang,Yin Li,Jie He

Diseases of the Esophagus（2021）

引用17浏览0WOS引用

Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study

Wen Zhang,Yong Li,Liyan Xue,Dong Qu,Zhichao Jiang,Zhen Wang,Zhaoyang Yang,Aiping Zhou

Cancer Management and Research（2021）

引用10浏览0WOS引用

Promising Efficacy of SHR‐1210, a Novel Anti–programmed Cell Death 1 Antibody, in Patients with Advanced Gastric and Gastroesophageal Junction Cancer in China

Jing Huang,Hongnan Mo,Weilong Zhang,Xuelian Chen,Dong Qu,Xi Wang,Dawei Wu,Xingyuan Wang,Bo Lan,Beibei Yang, Pei Wang,Bo Zhang,Qing Yang,Yuchen Jiao,Binghe Xu

CANCER（2019）

引用61浏览0WOS引用

Reactive Capillary Hemangiomas: a Novel Dermatologic Toxicity Following Anti-Pd-1 Treatment with SHR-1210

Xuelian Chen,Lanying Ma,Xi Wang,Hongnan Mo,Dawei Wu,Bo Lan,Dong Qu,Hongtu Zhang,Jing Huang,Binghe Xu

Cancer Biology and Medicine（2019）

引用90浏览0WOS引用

Safety, Anti-Tumour Activity, and Pharmacokinetics of Fixed-Dose SHR-1210, an Anti-Pd-1 Antibody in Advanced Solid Tumours: a Dose-Escalation, Phase 1 Study

Hongnan Mo,Jing Huang,Jiachen Xu,Xuelian Chen,Dawei Wu,Dong Qu,Xi Wang,Bo Lan,Xingyuan Wang,Jianping Xu,Honggang Zhang,Yihebali Chi,Qing Yang,Binghe Xu

British Journal of Cancer（2018）

引用140浏览0WOSNATURE引用

140

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn